Bioxytran, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 144.0% | 144.0% | -3,208.8% |
| FY2024 | 132.1% | 132.1% | -1,706.4% |
| FY2025 | 81.9% | 81.9% | -322.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 144.0% | 144.0% | -3,208.8% |
| FY2024 | 132.1% | 132.1% | -1,706.4% |
| FY2025 | 81.9% | 81.9% | -322.4% |